Edwards Lifesciences (EW) Enters $325M Accelerated Share Repurchase Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. CRDO
8. OIG
9. AMAT
10. SPY

Go back to Edwards Lifesciences (EW) Enters $325M Accelerated Share Repurchase Agreement

Edwards Lifesciences Announces $325 Million Accelerated Share Repurchase

February 4, 2016 6:34 PM EST

IRVINE, Calif., Feb. 4, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC to repurchase $325 million of Edwards' common stock.  This repurchase is part of the Company's... More